MAP3K20 and cystic fibrosis: Finally, eight candidate molecules (hsa-miR-144-3p, CCNE2, C9orf72, MAP3K20-AS1, LEF1-AS1, AC243772.2, FLJ46284, and AC239798.2) may be used as the diagnosis and treatment targets of CF and HF.